Karolinska Institutet
Stockholm, 171 77, Sweden
NCT Number: NCT01477125
The purpose of this study is to evaluate whether computerised working memory training improves cognitive performance, ADHD symptoms, psychosocial functioning and quality of life in adults with ADHD, from psychiatric outpatient clinics (N=100) as well as from a high-security prison facility (N=50).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Stockholm, 171 77, Sweden
The primary aim is to evaluate whether 5 weeks of computerised working memory training improves working memory capacity. Secondary aims are to explore whether improvements in working memory capacity will be transferred to improvements in learning abilities and fluid intelligence. Also, far transfer effects on executive functioning, ADHD symptoms, psychosocial functioning and quality of life will be explored. Finally, it will also be assessed to what extent improvements gained from 5 weeks of working memory training will be maintained 3 and 6 months post-study, respectively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30-40 minutes of working memory training, 5 days a week for 5 weeks
Time frame: Baseline and 7 weeks
The composite measure of working memory capacity comprises the sum score of:
Time frame: Baseline and 31 weeks
The composite measure of working memory capacity will be assessed in a 6-month follow-up conducted at week 31 post-baseline, equivalent to week 24 post-intervention, to assess retention of any training-related improvements.
Time frame: Baseline, 7 and 31 weeks
Evaluating changes in both Digit Span forwards and backwards scores, as measures of simple verbal working memory capacity.
Time frame: Baseline, 7 and 31 weeks
Evaluating changes in both Span Board forwards and backwards scores as measures of simple visuo-spatial working memory capacity.
Time frame: Baseline, 7 and 31 weeks
Evaluating change in Arithmetics score, as a measure of complex verbal working memory capacity as well as of mathematics ability.
Time frame: Baseline, 7 and 31 weeks
Evaluating change in Spatial Working Memory score as a measure of complex visuo-spatial working memory capacity.
Time frame: Baseline, 7 and 31 weeks
Evaluating changes in Qbtest, a computerised CPT that in addition to measuring inattention and impulsivity also captures motor activity by an IR device during performance of the CPT.
Time frame: Baseline, 7 and 31 weeks
Evaluating change in score of a short version of Raven´s Standard Progressive Matrices, as a measure of fluid intelligence.
Time frame: Baseline, 7, 19, and 31 weeks
Evaluating changes in ADHD symptoms by self-reported and informant-reported (significant other) versions of ASRS-v1.1, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Time frame: Baseline, 7, 19, and 31 weeks
Evaluating changes in psychosocial functioning by the self-reported SDS conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Time frame: Baseline, 7, 19, and 31 weeks
Evaluating change in health-related quality of life by the self-reported generic QoL questionnaire EQ-5D, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Time frame: Baseline, 7, 19, and 31 weeks
Evaluating change in health-related quality of life by the self-reported ADHD specific QoL measure AAQoL, conducted at baseline, post-intervention, at 3-month and 6-month follow-up.
Time frame: Baseline and 7 weeks
Evaluating if depressive symptoms during the training period, as measured by the self-reported MADRS-S will influence adherence to and results of the working memory training.
Time frame: Baseline and 7 weeks
All adverse events that occurred during the course of the 5-week intervention will be collected as part of the post-intervention assessments at week 7.
Karolinska Institutet
Other
Computerised Working Memory Training in Adults With ADHD: A Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05631626
ADHD, ADHD - Combined Type
Las Vegas, Nevada, United States
View Trial DetailsNCT05588713
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Uppsala, Sweden
View Trial DetailsNCT04561713
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Bordeaux, France
View Trial DetailsNCT05464056
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Chicago, Illinois, United States
View Trial Details